CMS reimbursement
-
How MIPS Value Pathways will Prove the Value of Rehab Therapy
As value-based care models take hold, the time is ripe for rehab therapists to position themselves as primary players in the movement toward delivering optimal quality and value in the broader healthcare ecosystem.
-
MedCity Influencers, Health Tech
How Rehab Therapists Can Use RTM to Optimize Patient Care
CMS has shown that they understand the value and efficacy of remote care as a billable service for rehab therapists—let’s not miss this opportunity to take the best care of our patients while getting paid.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
AppliedVR Earns First Unique CMS Code Ever Granted to a Digital Therapeutic
CMS recently established a unique code for AppliedVR’s flagship product, marking the first time a digital therapeutic or immersive therapeutic has ever been placed in an existing benefit category. The eight-week program is a physician-prescribed solution that allows patients to manage their chronic lower back pain without opioids from the comfort of their own home.
-
5 Factors Holding Back Healthcare Practices From Adopting RPM
Just a quarter of healthcare practices offer remote patient monitoring, and the majority of them aren’t too eager to adopt the technology any time soon, according to a new report. A few factors are influencing this reluctance, including data security concerns, unclear reimbursement policies and training requirements.
-
RTM Reimbursement Represents a New Age for Digital Therapeutics
Ultimately, it is anticipated that CMS will further expand the use of reimbursable RTM beyond respiratory and MSK care and incorporate patient-reported information as a requirement for reimbursement of certain remote services.
-
MedCity Influencers, Devices & Diagnostics, Opinion
Coverage delays exacerbate inequity for Medicare beneficiaries
Without reimbursement policies that can meet the opportunity of this new innovative era, patients and their providers will be denied access to the most cutting-edge, care.
-
How digital health is challenging traditional reimbursement models
The traditional fee-for-service arrangements have caused misaligned incentives across the board for patients, physicians, and payers – and proved a huge obstacle to improving care. Recognizing this gap, CMS began to facilitate a shift towards outcome-based care by focusing on outpatient monitoring and disease management. This has led to progress in adopting new reimbursement models.
-
What CMS’ virtual care moves mean for healthcare at large
In a phone interview, Matt Fisher, a partner with Mirick O’Connell, said CMS’ latest actions regarding virtual care are beneficial but noted doctors shouldn’t forget about the privacy and security side of the coin.
-
OIG report: CMS improperly reimbursed doctors $3.7M in telehealth payments
In a sample of 100 claims from 2014 and 2015, 69 met telehealth service requirements and the other 31 did not, resulting in an estimated $3.7 million in extra costs.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
2017: The year telehealth and digital health hit their stride
This year, CMS promised reimbursement changes for telemedicine and remote patient monitoring in 2018. Meanwhile, the FDA unveiled its pre-certification pilot program for digital health. Despite being significant, these noteworthy events leave room for improvement in 2018.
-
Small practices worried about new Medicare payment rules
“The ways it’s structured now, the large practices will do well and the small practices will do badly,” said Paul Ginsburg, director of the Center for Health Policy at the Brookings Institution.
-
Morning Read: Medicare shifting $900M to value-based care in 2017, FDA halts Juno trial after deaths
Plus, KaloBios makes plans to buy out Shkreli’s shares, medical device M&A value soars as even volume dips in H1, while the Brexit fallout continues in the pharma industry.
-
Does Medicare unfairly punish teaching hospitals?
The penalties, created by the federal Affordable Care Act, have incited a vehement debate about quality at many academic medical centers often revered for cutting-edge treatments and top specialists. Are these vaunted hospitals really more dangerous than local, unsung hospitals?